Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biossance Doubles Down On 'Free Of' Marketing With Ingredient Blacklist

This article was originally published in The Rose Sheet

Executive Summary

Biossance, the personal-care division of integrated renewable products company Amyris, has unveiled a blacklist of more than 2,000 cosmetic ingredients it "refuses to use" due to safety and environmental concerns. The company discusses its rationale for the move and the controls it has in place in a litigious environment where "free of" claims are under increasing attack.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019909

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel